Anesthesiological management of hypertrophic obstructive cardiomyopathy surgical correction
Abstract
Anestesiological management of surgical myectomy with and without mitral valve reconstruc-
tion have been evaluated in 29 patients with hypertrophic obstructive cardiomyopathy. Balanced use of midasolam, propofol, sevoflurane, fentanyl, pipecuronim bromide without ketamine was available to keep up the adequate homeostasis without increasing of left ventricular
dynamic obsrtuction. It was necessary to have sufficient preload, sinus rhythm, to prevent
of tachycardia, use of phenylephrine microdose, bolus or infusion esmolol without inotropic
drugs. Intraoperative transesophageal control is the obligatory method of dynamic evaluation
of anesthesiological management, left ventricular outflow tract obstruction, efficacy of surgical correction.
Keywords:hypertrophic cardiomyopathy, intraoperative transophageal echocardiography, general balanced anaesthesia
Clin. Experiment. Surg. Petrovsky J. 2018; 1 (19): 44–50.
DOI: 10.24411/2308-1198-2018-00007
Received: 03.01.2018. Accepted: 25.01.2018.
References
1. Bokeria L.A., Borisov K.V., Sinev A.F. Surgical correction
of hypertrophic cardiomyopathy after electrocardiostimulation.
Grudnaya i serdechno-sosudistaya khirurgiya [Thoracic and
Cardiovascular Surgery]. 2003; (6): 17–23. (in Russian)
2. Krychevsky L.A., Ribakov V.J., Guseva O.G., et al. Odstruction
of left ventricular tract in cardiosurgical operations. Anesteziologiya
i reanimatologiya [Anesthesiology and Reanimatology]. 2015;
69 (5): 31–4. (in Russian)
3. Tauncin M., Martin D. Anesthesia in surgical valvular
correction. In: F. Chensly, D. Martin, U. Grevly (eds). Ch. 12. Practical
Cardioaneststhesiology. Moscow: MIA, 2017. (in Russian)
4. Bell M., Goodchild C. Hypertrophic obstructive
cardiomyopathy in combination with a prolapsing mitral valve.
Anaesthesia for surgical correction with propofol. Anaesthesia.
1989; 44: 409–11.
5. Brown M., Shaff H., Su L.A. Surgical management
of obstructive hypertrophic cardiomyopathy. The gold standard.
Expert Rev Cardiovasc Ther. 2008; 6: 715–21.
6. Hanrath P., Mathey D., Kremer B., Sontag F., et al. Effect
of verapamil on left ventricular filling in hypertrophic obstructive
cardiomyopathy. Am J Cardiol. 1980; 45: 1258–64.
7. Maquoi I., Barbous A., Brichant J., Hans G. Dynamic left
ventricular outflow obstruction during non-cardiac surgery. Austin
J Anesth Analg. 2017; 5 (1).
8. Maron M., Olivotto I.,Zenovich A., et al. Hypertrophic
cardiomyopathy is predominantly disease of left ventricular outflow
tract obstruction. Circulation. 2006; 114: 2232–5.
9. Maron B., Shen W., Link M., et al. Efficacy of implantable
cardioverter-defibrillators for the prevention of sudden death
in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;
342: 365–70.
10. Oliver W., Mauermann W., Nuttall G. Uncommon cardiac
diseases. Ch. 22. In: Kaplan Cardiac Anesthesia. The Echo Era. 6th
ed. Saunders; Elsevier, 2011: 682–92.
11. Ommen S., Park S., Click R., et al. Impact of intraoperative
transesophageal echocardiography in the surgical management
of hypertrophic cardiomyopaphy. Am J Cardiol. 2002; 90: 1022–28.
12. Slama M., Tribouilloy C., Maizel J. Left ventricular outflow
tract obstruction in ICU patients. Curr Opin Crit Care 2016;
22: 260–6.
13. Stewart J., McKenna W. Management of arrhythmias in
hypertrophic cardiomyopaphy. Cardiovasc Drugs Ther. 1994; 8: 93–8.